How to Archive Paper vs Electronic TMF Records in Clinical Trials

Introduction: Two Paths to Regulatory Archiving

In clinical trials, managing and archiving the Trial Master File (TMF) is critical for compliance with global regulatory standards. As organizations shift from traditional paper-based systems to electronic TMFs (eTMFs), understanding how to properly archive each format—individually or in hybrid—is essential to ensure audit readiness and data integrity.

Regulatory agencies including the FDA and EMA emphasize that both paper and electronic records must remain complete, accurate, and accessible throughout their required retention period. This article explores how paper and electronic TMFs differ in archiving practices, requirements, and compliance risks.

Archiving Paper TMF Records: Physical Storage and Protection

Archiving paper TMF records involves transporting physical documents to a secure long-term storage facility. These archives must be protected from physical degradation, unauthorized access, and loss.

Key Paper Archiving Steps:

• Finalize and QC all documents before transfer
• Use acid-free boxes and clearly labeled folders
• Create an inventory index of all stored materials
• Assign a TMF archive custodian for access control
• Use barcode tracking for retrieval efficiency

Facilities should be temperature- and humidity-controlled, with fire suppression and restricted access. Archival contracts with third-party storage vendors must specify retention timelines, disaster recovery procedures, and destruction protocols.

Archiving eTMF Records: Ensuring Digital Longevity

eTMFs offer easier access, searchability, and version control, but require specific validation and file integrity safeguards when archiving digitally.

Best Practices for eTMF Archiving:

• Export documents into non-proprietary formats like PDF/A or TIFF
• Retain audit trails, metadata, and version histories
• Ensure platform compliance with 21 CFR Part 11 and EU Annex 11
• Use validated, read-only archive environments
• Implement regular backup and disaster recovery testing

Platforms such as Veeva Vault, MasterControl, and PhlexTMF offer eTMF modules with archiving capabilities. Ensure archived files remain accessible during retention—some regulators may require access up to 25 years post-trial.

For guidance on archiving SOPs and indexing templates, visit PharmaSOP.in.

Managing Hybrid TMFs: The Best (and Worst) of Both Worlds

Many clinical trial sponsors operate with a hybrid TMF—where some documents are stored electronically while others remain in paper form. While practical, this model introduces unique archiving challenges.

Best Practices for Hybrid TMF Archiving:

• Document clearly in the TMF plan which files are stored electronically vs. physically
• Ensure scanned documents are linked to original paper copies, or validate scanned images for destruction of originals
• Maintain a unified index across both formats for audit trail continuity
• Use cross-referenced folder naming conventions
• Define clear roles for both eTMF administrator and paper archive custodian

Regulators may inspect both components of a hybrid TMF simultaneously. Ensure both are synchronized, complete, and verifiable. Discrepancies between scanned and physical documents can lead to major compliance findings.

Compliance Risks in Archiving TMF Records

Regardless of the format, TMF archiving that fails to follow GCP guidelines can jeopardize trial integrity and regulatory approval. Common mistakes include:

• Lack of archiving SOPs: Many sites treat archiving as an afterthought, without defined procedures
• Unvalidated eTMF platforms: Archiving on non-compliant systems fails 21 CFR Part 11 audits
• Missing inventory logs: Paper TMFs without index records are difficult to navigate during inspections
• Inaccessible archives: Long-term archives must be retrievable even years later

As per EMA inspection reports, archival errors such as uncontrolled document destruction or expired access credentials can lead to serious findings.

Inspection Readiness: What Auditors Will Look For

Auditors will evaluate both how TMF documents are archived and how easily they can be retrieved. Whether using paper or eTMF systems, prepare for the following audit queries:

• “Where are your archived documents stored?”
• “Can you show evidence of audit trail retention for digital files?”
• “What system do you use for barcode tracking in paper archives?”
• “Do your archive facilities meet environmental and security standards?”

Prepare by conducting internal mock audits focused solely on TMF archiving practices. Validate that your SOPs, training records, and system access logs are all inspection-ready.

Key Differences Between Paper and eTMF Archiving

Conclusion: Choosing the Right Archiving Approach

Whether using paper, electronic, or hybrid TMFs, compliance starts with a well-defined archive strategy. From inventory management and SOPs to validated platforms and custodianship, the success of your TMF archiving program directly impacts your regulatory outcomes.

While eTMFs offer speed and traceability, paper archives remain common—especially in legacy trials and multi-center studies. The key is ensuring that whatever method you use, it complies with the expectations of FDA, EMA, and other authorities.

For archiving templates, scanning protocols, and audit readiness checklists, visit PharmaValidation.in.

Regulatory Guidelines for TMF Archiving: ICH, FDA & EMA Explained

Why TMF Archiving is a Regulatory Imperative

Trial Master File (TMF) archiving ensures that essential clinical trial documents are retained, accessible, and protected long after the study concludes. Regulatory authorities such as the ICH, FDA, and EMA mandate strict requirements for the retention, accessibility, and integrity of archived TMFs.

Failure to properly archive TMF documents can result in inspection findings, legal liabilities, and a loss of trial credibility. This article provides a step-by-step guide to help sponsors, CROs, and clinical trial teams comply with global regulatory requirements for TMF archiving.

ICH Guidelines for TMF Retention

ICH E6(R2) Section 8 outlines expectations for the storage and retention of essential documents. According to the guideline:

• TMF documents must be retained for at least 2 years after the last marketing approval or discontinuation of development.
• All documents must be stored in a way that ensures legibility, integrity, and accessibility.
• Archiving procedures should be governed by written SOPs detailing media, access control, and destruction timelines.

ICH emphasizes both physical and electronic archiving practices, making the consistency of document metadata and audit trails essential components.

FDA Expectations for TMF Archiving

The FDA requires that sponsors and investigators maintain study records under 21 CFR Part 312 (for IND studies) and 21 CFR Part 812 (for IDE studies). Key requirements include:

• Retention of records for 2 years following the date a marketing application is approved or the investigation is discontinued.
• Clear identification of the location and custodians of archived records.
• Availability of records for FDA inspection at any time during the retention period.
• Secure backup and data recovery plans for electronic records, especially those governed under 21 CFR Part 11.

Sponsors should ensure that any offsite archiving facility is pre-qualified and compliant with GMP and GCP principles.

EMA TMF Archiving Requirements

The EMA mandates compliance with EudraLex Volume 10 and EU Regulation 536/2014. EMA expectations include:

• Essential documents must be retained for at least 25 years after the end of the clinical trial.
• Archived TMF must be readily available for inspection, even if stored digitally or offsite.
• Archived documents must be protected against unauthorized access, alteration, and loss.
• Electronic documents must remain readable throughout the entire retention period.

Sponsors must implement processes to ensure that future technological changes do not render archived electronic files inaccessible (e.g., obsolete formats).

For document control SOP templates related to archiving, visit PharmaSOP.in.

Archiving Electronic TMF (eTMF): Technical and Regulatory Considerations

As sponsors transition from paper to electronic TMFs, ensuring long-term accessibility and data integrity becomes a critical regulatory requirement. eTMF archiving must consider both the digital infrastructure and evolving technology risks.

Key eTMF Archiving Considerations:

• Non-Proprietary Formats: Store files in PDF/A, TIFF, or XML to ensure future readability.
• Metadata Preservation: Retain all indexing data and document attributes for traceability.
• Encryption & Access Control: Use role-based access to protect documents from unauthorized modification.
• Time-Stamped Audit Trails: Ensure every user action is logged and preserved with time stamps.

eTMF vendors like Veeva Vault, PhlexTMF, and MasterControl offer long-term archiving modules. Sponsors must verify that these systems meet the requirements under 21 CFR Part 11 and Annex 11.

Maintaining TMF Accessibility During Retention Periods

One of the most overlooked aspects of archiving is ensuring ongoing access to TMF documents throughout the required retention period. Regulatory inspectors may request to review archived files even years after study closure.

Best practices include:

• Conducting annual archive access drills to confirm retrievability
• Maintaining an archive access SOP and designating archive custodians
• Creating an archive location log with detailed metadata
• Using dual-location backup for disaster recovery

For example, the FDA may inspect a discontinued IND study if post-market safety signals arise. If TMF access is delayed or denied, the sponsor risks a 483 observation or Warning Letter.

Developing a TMF Archival SOP

An archival SOP must define the procedures for physical and electronic TMF storage, including:

• Archiving triggers (e.g., study closeout, final CSR submission)
• Access and withdrawal procedures
• Record destruction policies
• Indexing and metadata documentation
• Vendor qualification and monitoring

Sponsors should include sample archival forms, responsibility matrices, and audit checklists in the SOP package. These documents may be reviewed during sponsor inspections.

Preparing for Archival Audits and Inspections

Auditors and regulators may include archival review as part of a broader inspection. Common questions include:

• “Where is the archived TMF located?”
• “How quickly can you retrieve a signed ICF from a 5-year-old study?”
• “Who is the designated custodian for your legacy TMF files?”
• “Have you tested eTMF retrievability in the past year?”

Companies can prepare by conducting annual mock inspections focused solely on TMF archiving and retrieval processes.

Conclusion: Archiving as a Pillar of GCP Compliance

TMF archiving isn’t just an administrative formality—it is a regulatory obligation with legal, ethical, and operational consequences. Compliance with ICH, FDA, and EMA expectations ensures that critical documents remain accessible and auditable for years to come.

Whether managing paper, hybrid, or fully digital TMFs, organizations must invest in robust archiving SOPs, secure infrastructure, and periodic verification to protect the integrity of their trial records.

For validated archiving templates, vendor qualification checklists, and mock audit guides, visit PharmaValidation.in.